Rat angiotensin II (type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy
- PMID: 8348688
- DOI: 10.1161/01.res.73.3.439
Rat angiotensin II (type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy
Abstract
Two subtypes of angiotensin II (Ang II) receptors (AT1 and AT2) are distinguished by using the respective specific antagonists. In the present study, we report the regulation of cardiac AT1 type A (AT1A) receptor mRNA levels and the expression pattern of AT1 and AT2 receptors in the growth of the heart and the development and regression of cardiac hypertrophy. The ventricular AT1A mRNA level and the density of Ang II receptors at the neonatal period were significantly increased (3.5-fold and 2.5-fold, respectively) and then downregulated with maturation. The cardiac hypertrophy established in spontaneously hypertensive rats or two-kidney one-clip renovascular hypertensive rats resulted in substantial increases in ventricular AT1A mRNA levels (threefold) and Ang II receptor densities (twofold) as compared with those in respective control rats, whereas the receptor affinity was similar. The proportion of AT1 and AT2 subtypes in the specific Ang II binding in ventricular membranes prepared from normal adult rats was nearly equal. This proportion did not change significantly in the development of myocardial hypertrophy. The regression of cardiac hypertrophy by the normalization of elevated blood pressure completely reversed the increased levels of AT1A mRNA and the receptor density to the control level. Thus, AT1 and AT2 receptors are present in rat ventricular myocardium, and their expression is developmentally regulated and upregulated in response to hypertrophic change. Ang II action exerted through the increased number of Ang II receptors may contribute to the growth of the heart and thus to the maintenance of established hypertrophy as one of the hormones involved in hypertrophy development.
Similar articles
-
Angiotensin II receptor subtype AT1 and AT2 expression after heart transplantation.Cardiovasc Res. 1998 May;38(2):340-7. doi: 10.1016/s0008-6363(98)00015-7. Cardiovasc Res. 1998. PMID: 9709394
-
Cardiac senescence is associated with enhanced expression of angiotensin II receptor subtypes.Endocrinology. 1998 May;139(5):2579-87. doi: 10.1210/endo.139.5.6023. Endocrinology. 1998. PMID: 9564874
-
Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats.Hypertension. 1997 Oct;30(4):796-802. doi: 10.1161/01.hyp.30.4.796. Hypertension. 1997. PMID: 9336375
-
The renin-angiotensin system and experimental heart failure.Cardiovasc Res. 1999 Sep;43(4):838-49. doi: 10.1016/s0008-6363(99)00145-5. Cardiovasc Res. 1999. PMID: 10615411 Review.
-
Involvement of angiotensin II in cardiovascular and renal injury: effects of an AT1-receptor antagonist on gene expression and the cellular phenotype.J Hypertens Suppl. 1997 Dec;15(6):S3-7. J Hypertens Suppl. 1997. PMID: 9493120 Review.
Cited by
-
Cellular Interplay between Cardiomyocytes and Nonmyocytes in Cardiac Remodeling.Int J Inflam. 2011;2011:535241. doi: 10.4061/2011/535241. Epub 2011 Sep 18. Int J Inflam. 2011. PMID: 21941677 Free PMC article.
-
The role of mAKAPβ in the process of cardiomyocyte hypertrophy induced by angiotensin II.Int J Mol Med. 2015 May;35(5):1159-68. doi: 10.3892/ijmm.2015.2119. Epub 2015 Mar 2. Int J Mol Med. 2015. PMID: 25739102 Free PMC article.
-
Diverse factors influencing angiotensin metabolism during ACE inhibition: insights from molecular biology and genetic studies.Br Heart J. 1994 Sep;72(3 Suppl):S3-10. doi: 10.1136/hrt.72.3_suppl.s3. Br Heart J. 1994. PMID: 7946800 Free PMC article. Review. No abstract available.
-
The increased angiotensin II (type 1) receptor density in myocardium of type 2 diabetic patients is prevented by blockade of the renin-angiotensin system.Diabetologia. 2006 Dec;49(12):3067-74. doi: 10.1007/s00125-006-0444-8. Epub 2006 Oct 19. Diabetologia. 2006. PMID: 17051401
-
Development of pressure overload induced cardiac hypertrophy is unaffected by long-term treatment with losartan.Mol Cell Biochem. 1998 Nov;188(1-2):225-33. Mol Cell Biochem. 1998. PMID: 9823028
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous